Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11420972 Methods and compounds for treating

Patent 11420972 was granted and assigned to Gilead Sciences on August, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Gilead Sciences
Gilead Sciences
0
Date Filed
May 20, 2020
0
Date of Patent
August 23, 2022
0
Patent Applicant
Gilead Sciences
Gilead Sciences
0
Patent Application Number
16879491
0
Patent Citations
‌
US Patent 10034893 5, 6-D
‌
US Patent 10059716 Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
‌
US Patent 10065958 Methods and compounds for treating Paramyxoviridae virus infections
‌
US Patent 10251898 Methods for treating Filoviridae virus infections
‌
US Patent 10251904 Methods for treating arenaviridae and coronaviridae virus infections
‌
US Patent 10377761 Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
‌
US Patent 10675296 Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
‌
US Patent 10682368 Methods of treating feline coronavirus infections
‌
US Patent 10695357 Methods for treating filoviridae virus infections
‌
US Patent 10695361 Methods for treating arenaviridae and coronaviridae virus infections
•••
Patent Inventor Names
Adrian S. Ray
0
Dorothy Agnes Theodore
0
Jay P. Parrish
0
Richard L. Mackman
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11420972
0
Patent Primary Examiner
‌
Jeffrey S Lundgren
0

Find more entities like US Patent 11420972 Methods and compounds for treating

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo